One new idea on mitigating higher drug prices is to require the posting of costs in Rx advertising. This Kaiser Health News article provides illustrative examples of how this might look for the 10 drugs with the highest annual ad spend. Connecture data used.

SmartBrief spoke with Connecture President and CEO Jeff Surges about the roots of healthcare consumerism and key steps health plans can take to empower consumers.

Journalist Sarah Jane Tribble wrote a fascinating piece for the Washington Post that uses Connecture drug data and spotlights the Orphan Drug Korlym. This drug has a controversial origin as “the abortion pill,” but is also used to treat Cushing’s syndrome…and its price has shot up.

Fascinating Bloomberg story that leverages Connecture’s data and highlights a Chicago-based duo that’s selling a simple Rx strategy — and companies they’ve worked with have raised prices on drugs as much as 4,116%.

Earlier this month, Connecture hosted its first-ever FMO Council Meeting in its Chicago Innovation Hub. Connecture SVP and broker expert Joe Donlan writes about that experience and his three biggest takeaways from that session.

In her latest article, Bloomberg’s Rebecca Spalding discusses the role drug prices are playing in American politics. Connecture prescription drug data is featured.

Health insurance is always making headlines these days, particularly as Washington continues to debate over the ACA. But what about the non-traditional benefits that don’t get nearly as much coverage? Our own Amy Christofis explore this topic and their future.

Last month, Connecture hosted a webinar with Deft Research to unveil findings from the AEP 2018. In a piece for ThinkAdvisor, journalist Allison Bell discusses some of the learnings from the webinar and implications for carriers and members alike.